Form D · Pharmaceuticals
Sprout2 Inc.
Raleigh, NC · CIK 0001725755
Offering snapshot reported Dec 23, 2024 · SEC filing
- Reported sold
- $10.6M Offering amount: $12M
- Investors reported
- 51 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 10, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 23, 2024 | Initial | $10,557,600 | No comparison | 51 | SEC filing |
| Apr 14, 2023 | Initial | $7,064,364 | No comparison | 43 | SEC filing |
| Aug 15, 2022 | Amendment | $27,969,129 | $2,900,000vs May 6, 2022 | 91 | SEC filing |
| May 6, 2022 | Amendment | $25,069,129 | $12,673,000vs Sep 15, 2021 | 85 | SEC filing |
| Sep 15, 2021 | Amendment | $12,396,129 | $4,270,000vs Dec 10, 2020 | 64 | SEC filing |
| Dec 10, 2020 | Initial | $8,126,129 | No comparison | 59 | SEC filing |
| Aug 16, 2019 | Initial | $15,900,000 | No comparison | 110 | SEC filing |
| Jan 4, 2018 | Initial | $4,500,000 | No comparison | 203 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-533125
Source: Form D, filed Dec 23, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eric Atkins | Executive |
| Gail Becker | Director |
| Robert Dahl | Director |
| W. Robert Dahl | Director |
| Cynthia Eckert | Director, Executive |
| Margaret Henry | Executive |
| Sandra Mc Glothlin | Director |
| Adele Oliva | Director |
| Matthew Petzold | Executive |
| Robert Whitehead | Director |
| Cynthia Whitehead | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4350 Lassiter At North Hills Ave. Suite 260
Raleigh, NC, 27609
Raleigh, NC, 27609